BDNF and breast carcinoma: Downregulated chemoresistance cell feature genes were enriched in “Metabolic pathways” and “Neurotrophin signaling pathways” (Supplementary Figures S1G, H). The enrichment of these functions suggested that breast cancer chemo-resistant cells may resist chemotherapy by slowing down the cell cycle and strengthening DNA repair and synthesis.